Maria T. Scupoli

Verona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Journal: Leukemia
Published: June 24, 2026

Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Journal: Cancers
Published: November 20, 2025

B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma.

B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma.

Journal: Cell communication and signaling : CCS
Published: August 01, 2025

CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia.

CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia.

Journal: Hematological oncology
Published: August 20, 2024

Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair.

Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair.

Journal: Immunity
Published: July 31, 2024

B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.

B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.

Journal: Scientific reports
Published: October 31, 2023

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Journal: Leukemia
Published: December 20, 2022

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.

Journal: Signal transduction and targeted therapy
Published: November 15, 2022

Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.

Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.

Journal: Cells
Published: May 31, 2022

The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia.

The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia.

Journal: Cellular and molecular life sciences : CMLS
Published: April 14, 2022

Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells.

Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells.

Journal: Molecules (Basel, Switzerland)
Published: December 29, 2021

Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC.

Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC.

Journal: Biomolecules
Published: December 03, 2021
Showing 1-12 of 55

Last Updated: 09/26/2026